With Bitcoin's erratic price movements plaguing crypto markets, many investors are asking: Should I buy Bitcoin in 2018?
The truth is that even with Bitcoin trading 64% higher from this time last year, it's still a bargain price.
You see, Bitcoin is still undervalued as a method of storing value and making payments.
The underlying technology for Bitcoin, called blockchain, is considered revolutionary and is already being adopted by some of the biggest firms in the world. It will eventually disrupt everything from banking to the medical industry to music sales.
Top Undervalued Stocks To Own Right Now: Lancaster Colony Corporation(LANC)
Advisors' Opinion:- [By Motley Fool Transcribing]
Lancaster Colony (NASDAQ:LANC) Q4 2018 Earnings Conference CallAug. 23, 2018 10:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Max Byerly]
BidaskClub upgraded shares of Lancaster Colony (NASDAQ:LANC) from a strong sell rating to a sell rating in a report released on Wednesday.
Separately, Zacks Investment Research raised shares of Lancaster Colony from a strong sell rating to a hold rating in a research report on Thursday, April 12th.
Top Undervalued Stocks To Own Right Now: ImmuCell Corporation(ICCC)
Advisors' Opinion:- [By Stephan Byrd]
ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.
- [By Max Byerly]
ImmuCell Co. (NASDAQ:ICCC) Director David Scott Tomsche purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, August 16th. The stock was purchased at an average cost of $6.67 per share, with a total value of $20,010.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Top Undervalued Stocks To Own Right Now: Platform Specialty Products Corporation(PAH)
Advisors' Opinion:- [By Ethan Ryder]
Cubist Systematic Strategies LLC acquired a new position in Platform Specialty Products Corp (NYSE:PAH) in the second quarter, Holdings Channel reports. The fund acquired 39,513 shares of the specialty chemicals company’s stock, valued at approximately $458,000.
- [By Shane Hupp]
Platform Specialty Products Corp (NYSE:PAH) Director Ian G. H. Ashken acquired 10,000 shares of the company’s stock in a transaction on Monday, August 13th. The stock was acquired at an average cost of $12.08 per share, with a total value of $120,800.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Platform Specialty Products (PAH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Shares of Platform Specialty Products Co. (NYSE:PAH) have earned a consensus rating of “Hold” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $14.40.
- [By Ethan Ryder]
Victory Capital Management Inc. decreased its stake in Platform Specialty Products Corp (NYSE:PAH) by 0.2% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 3,692,379 shares of the specialty chemicals company’s stock after selling 8,086 shares during the period. Victory Capital Management Inc.’s holdings in Platform Specialty Products were worth $42,832,000 at the end of the most recent quarter.
- [By Max Byerly]
Get a free copy of the Zacks research report on Platform Specialty Products (PAH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment